AgeX Therapeutics Statistics Share Statistics AgeX Therapeutics has 2.5M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 2.5M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 2.45M Failed to Deliver (FTD) Shares 104 FTD / Avg. Volume 2.61%
Short Selling Information The latest short interest is 69.39K, so 0% of the outstanding
shares have been sold short.
Short Interest 69.39K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 7.59
Valuation Ratios The PE ratio is -7.33 and the forward
PE ratio is null.
AgeX Therapeutics's PEG ratio is
0.08.
PE Ratio -7.33 Forward PE n/a PS Ratio 1458.66 Forward PS n/a PB Ratio 127.43 P/FCF Ratio -4.76 PEG Ratio 0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AgeX Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.4,
with a Debt / Equity ratio of 0.42.
Current Ratio 2.4 Quick Ratio 2.4 Debt / Equity 0.42 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 32.41
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $14K Profits Per Employee $-2.79M Employee Count 4 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.19, so AgeX Therapeutics's
price volatility has been higher than the market average.
Beta 1.19 52-Week Price Change n/a 50-Day Moving Average 13.98 200-Day Moving Average 20.11 Relative Strength Index (RSI) 41.05 Average Volume (20 Days) 3,980
Income Statement In the last 12 months, AgeX Therapeutics had revenue of 56K
and earned -11.14M
in profits. Earnings per share was -1.51.
Revenue 56K Gross Profit n/a Operating Income -17.05M Net Income -11.14M EBITDA -17.05M EBIT n/a Earnings Per Share (EPS) -1.51
Full Income Statement Balance Sheet The company has 3.67M in cash and 268K in
debt, giving a net cash position of 3.4M.
Cash & Cash Equivalents 3.67M Total Debt 268K Net Cash 3.4M Retained Earnings -44.32M Total Assets 6.73M Working Capital 3.4M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -17.14M
and capital expenditures -22K, giving a free cash flow of -17.16M.
Operating Cash Flow -17.14M Capital Expenditures -22K Free Cash Flow -17.16M FCF Per Share -2.33
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin -30442.86% Pretax Margin -19894.64% Profit Margin -19894.64% EBITDA Margin -30442.86% EBIT Margin -30442.86% FCF Margin -30641.07%
Dividends & Yields AGE does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for AGE.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 15, 2024. It was a
backward
split with a ratio of 100:3517.
Last Split Date Mar 15, 2024 Split Type backward Split Ratio 100:3517
Scores Altman Z-Score -13.45 Piotroski F-Score 4
